Cardiometabolic risk in non-diabetic metabolic dysfunction-associated steatotic liver disease (MAFLD) patients: insights from the triglyceride-glucose, plasma atherogenic, and cardiometabolic index

Cardiometabolic risk in non-diabetic metabolic dysfunction-associated steatotic liver disease (MAFLD) patients: insights from the triglyceride-glucose, plasma atherogenic, and cardiometabolic index

Introduction The objective of our study was to examine the correlation between hepatosteatosis and the triglyceride-glucose index (TyG), plasma atherogenic index (PAI), and cardiometabolic index (CMI) in nondiabetic patients. We also aimed to assess the usefulness of these indices in evaluating card...

Full description

Saved in:
Bibliographic Details
Main Authors: Sedat Ciftel, Serpil Çiftel, Ahmed R. Baykan, Serkan Cerrah, Enver Çiftel, Filiz Mercantepe
Format: Article
Language:English
Published: Termedia Publishing House 2024-07-01
Series:Archives of Medical Science
Subjects:
metabolic dysfunction-associated steatotic liver disease
cardiometabolic risk
cardiometabolic index
triglyceride-glucose index
plasma atherogenic index
Online Access:https://www.archivesofmedicalscience.com/Cardiometabolic-risk-in-non-diabetic-metabolic-dysfunction-associated-steatotic-liver,190867,0,2.html
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.archivesofmedicalscience.com/Cardiometabolic-risk-in-non-diabetic-metabolic-dysfunction-associated-steatotic-liver,190867,0,2.html

Similar Items